Long-term efficacy of a combination of amlodipine and olmesartan medoxomil±hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial

A prespecified subgroup analysis of a 44-week open-label extension study is presented. The efficacy and safety of the combination of amlodipine (AML)+ olmesartan medoxomil (OM), with and without the addition of hydrochlorothiazide (HCTZ), were investigated in patients aged ⩾65 and <65 years, Blac...

Descripción completa

Detalles Bibliográficos
Autores principales: Oparil, S, Chrysant, S G, Melino, M, Lee, J, Karki, S, Heyrman, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990108/
https://www.ncbi.nlm.nih.gov/pubmed/20200547
http://dx.doi.org/10.1038/jhh.2010.16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990108/
https://www.ncbi.nlm.nih.gov/pubmed/20200547
http://dx.doi.org/10.1038/jhh.2010.16

Ejemplares similares